Romosozumab May Be the Next Big Treatment for Osteoporosis

This monoclonal antibody binds to sclerostin, thus stimulating bone formation.

Source: Medscape ObGyn Podcast - February 11, 2014 Category: OBGYN Authors: Medscape Source Type: podcasts